Benzodiazepine Prescribing in Nebraska
Medicare Part D, 2013–2024.
Benzodiazepine prescribing in Nebraska fell 2.6% between 2013 and 2024 — a slower fall than the country as a whole. In 2024 the state recorded 204,678 Medicare Part D benzodiazepine claims across 39,694 patients, an average of 5.16 fills per patient per year, which ranks 10 of 51 states. Alprazolam accounts for 34.8% of it.
Nebraska over twelve years
Which benzodiazepines Nebraska prescribes
| Drug | Claims 2024 | Share |
|---|---|---|
| Alprazolam | 71,312 | 34.8% |
| Lorazepam | 58,028 | 28.4% |
| Clonazepam | 52,122 | 25.5% |
| Diazepam | 13,324 | 6.5% |
| Temazepam | 7,945 | 3.9% |
Psychiatric prescribers in Nebraska
97 psychiatric prescribers in Nebraska appear in the 2024 Medicare Part D data with benzodiazepine claims. 15 of them recorded at least a 50% fall in benzodiazepine claims since 2019. Sorted by change, largest reduction first.
This is a record, not a recommendation. A fall in Medicare benzodiazepine claims has many possible explanations — a changing patient panel, retirement, a shift to another payer, or simply dropping below the threshold CMS publishes. It does not establish that a prescriber supports tapering, and a low number does not mean they will take you as a patient. Use it as one input, then ask the five vetting questions.
| Prescriber | City | 2019 | 2024 | Change |
|---|---|---|---|---|
| Stephen SalzbrennerPsychiatry | Omaha | 350 | 22 | -93.7% |
| Hasnain SadiqPsychiatry | Omaha | 1,002 | 89 | -91.1% |
| Hugo Gonzalez NietoPsychiatry | Kearney | 197 | 18 | -90.9% |
| Narendra ReddyPsychiatry | Omaha | 999 | 185 | -81.5% |
| Lauren EdwardsPsychiatry | Omaha | 147 | 29 | -80.3% |
| Joseph KentPsychiatry | Omaha | 155 | 32 | -79.4% |
| Mark DiercksPsychiatry | Omaha | 256 | 68 | -73.4% |
| Sharon HammerPsychiatry | Omaha | 44 | 13 | -70.5% |
| Preeti DusajPsychiatry | Hastings | 228 | 68 | -70.2% |
| Kavir SaxenaPsychiatry | Hastings | 315 | 98 | -68.9% |
| Katelyn ThompsonPsychiatry | Omaha | 269 | 116 | -56.9% |
| Dana RamlPsychiatry | Omaha | 30 | 13 | -56.7% |
| Vithyalakshmi SelvarajPsychiatry | Omaha | 238 | 106 | -55.5% |
| Praveen FernandesPsychiatry | Omaha | 1,021 | 509 | -50.1% |
| Janet McgivernPsychiatry | Omaha | 92 | 46 | -50% |
| Sheritta StrongPsychiatry | Omaha | 778 | 394 | -49.4% |
| Navdeep SoodPsychiatry | Grand Island | 432 | 229 | -47% |
| Mark ScanlanPsychiatry | Scottsbluff | 454 | 243 | -46.5% |
| Marin BroucekPsychiatry | Omaha | 238 | 133 | -44.1% |
| Michael GoodmanPsychiatry | Omaha | 43 | 31 | -27.9% |
| Jose Gary NadalaPsychiatry | Lincoln | 401 | 291 | -27.4% |
| Arun SharmaPsychiatry | Omaha | 948 | 708 | -25.3% |
| Michael CoyPsychiatry | Omaha | 158 | 120 | -24.1% |
| Dianna ClynePsychiatry | Lincoln | 791 | 617 | -22% |
| James SorrellPsychiatry | Omaha | 56 | 44 | -21.4% |
| Brian LubberstedtPsychiatry | Omaha | 14 | 11 | -21.4% |
| Narayana KoduriPsychiatry | North Platte | 1,010 | 845 | -16.3% |
| Michael EggerPsychiatry | Omaha | 662 | 562 | -15.1% |
| Jeffrey CoffmanPsychiatry | Lincoln | 359 | 337 | -6.1% |
| Michael SedlacekPsychiatry | Omaha | 731 | 688 | -5.9% |
| Sidney KauzlarichPsychiatry | Omaha | 64 | 65 | +1.6% |
| Cheryl BudaPsychiatry | Omaha | 408 | 421 | +3.2% |
| Jane TheobaldPsychiatry | Omaha | 91 | 94 | +3.3% |
| Corey MaybergerPsychiatry | Norfolk | 83 | 87 | +4.8% |
| Julie DicksonPsychiatry | Omaha | 123 | 139 | +13% |
| Chelsea ChesenPsychiatry & Neurology | Omaha | 73 | 83 | +13.7% |
| Rodney NitcherPsychiatry | Omaha | 917 | 1,048 | +14.3% |
| Mary Jo HaniganPsychiatry | Omaha | 193 | 223 | +15.5% |
| Ahsan NaseemPsychiatry | Lincoln | 83 | 96 | +15.7% |
| Thomas MagnusonGeriatric Psychiatry | Omaha | 574 | 678 | +18.1% |
| Walter DuffyPsychiatry | Lincoln | 1,267 | 1,503 | +18.6% |
| Erin KindredPsychiatry & Neurology | Omaha | 64 | 76 | +18.8% |
| Danielle BudaPsychiatry & Neurology | Lincoln | 123 | 152 | +23.6% |
| Madeline WestPsychiatry | Omaha | 27 | 36 | +33.3% |
| Roberto CervantesPsychiatry | Omaha | 499 | 670 | +34.3% |
| Madhuri PulluriPsychiatry | Omaha | 17 | 24 | +41.2% |
| Venkata KolliPsychiatry | Omaha | 213 | 313 | +46.9% |
| Steven WengelGeriatric Psychiatry | Omaha | 296 | 477 | +61.1% |
| Rachel FaustPsychiatry | Hastings | 342 | 570 | +66.7% |
| Syed SattarPsychiatry | Omaha | 411 | 697 | +69.6% |
| Tenycia ShepherdPsychiatry | Omaha | 58 | 101 | +74.1% |
| Siva Sundeep KoppoluPsychiatry & Neurology | Omaha | 51 | 97 | +90.2% |
| Jayakrishna MadabushiPsychiatry | Omaha | 687 | 1,358 | +97.7% |
| Rashmi OjhaPsychiatry | Columbus | 165 | 373 | +126.1% |
| Niranjan KcPsychiatry | Omaha | 15 | 44 | +193.3% |
| Erin RanumPsychiatry & Neurology | Omaha | 158 | 510 | +222.8% |
| Elizabeth FitzpatrickPsychiatry & Neurology | Omaha | 37 | 142 | +283.8% |
| Prashanth SripalPsychiatry & Neurology | Omaha | 92 | 431 | +368.5% |
| Sriram RamaswamyPsychiatry | Omaha | 14 | 95 | +578.6% |
| Spencer GallnerPsychiatry | Omaha | 26 | 179 | +588.5% |
| Babuji GandraPsychiatry | Omaha | 223 | 1,748 | +683.9% |
| Benjamin RowleyPsychiatry & Neurology | Omaha | 107 | 897 | +738.3% |
| Andrew ReussPsychiatry & Neurology | Omaha | — | 474 | — |
| Hwan-Shyr DingPsychiatry | North Platte | — | 315 | — |
| Deandre BluittPsychiatry | Omaha | — | 309 | — |
| Patricia BohartPsychiatry | Lincoln | — | 283 | — |
| Alisandrea ElsonPsychiatry | Omaha | — | 227 | — |
| Kelli BremerPsychiatry & Neurology | Lincoln | — | 184 | — |
| Ryan SantinPsychiatry | Lincoln | — | 135 | — |
| Mustafa RahmanPsychiatry & Neurology | North Platte | — | 122 | — |
| Bryndis GrissomPsychiatry & Neurology | Omaha | — | 105 | — |
| Angelo ZienoPsychiatry & Neurology | Omaha | — | 71 | — |
| William KingPsychiatry | Omaha | — | 58 | — |
| Riley MachalPsychiatry | Omaha | — | 54 | — |
| Melissa O'DellPsychiatry | Omaha | — | 51 | — |
| Juvet ChePsychiatry | Omaha | — | 44 | — |
| Alexandra BurtPsychiatry & Neurology | Omaha | — | 40 | — |
| Kellen AndersenPsychiatry & Neurology | Omaha | — | 34 | — |
| Mark ThomsenPsychiatry | Omaha | — | 33 | — |
| Thomas BainterPsychiatry & Neurology | Omaha | — | 33 | — |
| Logan FordPsychiatry & Neurology | Omaha | — | 32 | — |
| Ashley WaltersPsychiatry | Omaha | — | 30 | — |
| Mukanya TchombelaPsychiatry & Neurology | Omaha | — | 23 | — |
| Albert DickanPsychiatry & Neurology | Omaha | — | 19 | — |
| Emily RoyerPsychiatry | Columbus | — | 19 | — |
| Melody NewsonPsychiatry | Omaha | — | 18 | — |
| Harrison GreenePsychiatry & Neurology | Omaha | — | 16 | — |
| Haley Schuster-WilliamsPsychiatry & Neurology | Omaha | — | 14 | — |
| Martin HarringtonPsychiatry & Neurology | Omaha | — | 13 | — |
| Praneeth ThadiNeuropsychiatry | Omaha | — | 13 | — |
| John FranzenPsychiatry | Omaha | — | 12 | — |
| Saadiya JabbarPsychiatry & Neurology | Offutt Afb | — | 11 | — |
| Aarti GuptaPsychiatry | Omaha | — | 11 | — |
| Vijay DewanPsychiatry | Omaha | 44 | 492 | +1018.2% |
| William MarcilPsychiatry | Omaha | 19 | 459 | +2315.8% |
| David MarshallPsychiatry | Omaha | 12 | 298 | +2383.3% |
| Andrew BaumgartnerPsychiatry | Omaha | 14 | 373 | +2564.3% |
Figures are reproduced from the CMS public use files without alteration. Clinicians who believe a row misstates their record can write to support@taperoffbenzos.com and we will check it against the source file and correct or remove it.
Finding a prescriber in Nebraska
This data describes prescribing patterns; it does not tell you who will support a slow taper. For that, our guide to finding a benzo-wise prescriber compares every free provider directory that exists and lists the five questions that predict how a taper will go. If you already have a prescriber, the taper calculator generates a schedule to review with them.
Frequently asked questions
Is benzodiazepine prescribing rising or falling in Nebraska?
It fell 2.6% between 2013 and 2024 in Medicare Part D — a slower fall than the country as a whole, where prescribing fell 12.9%. In 2024, Nebraska recorded 204,678 benzodiazepine claims across 39,694 patients.
How does Nebraska compare to other states?
Nebraska ranks 10 of 51 for prescribing intensity, at 5.16 benzodiazepine fills per patient per year, and 41 of 51 for the size of its decline since 2013 (1 being the steepest fall).
Which benzodiazepine is prescribed most in Nebraska?
Alprazolam, at 71,312 claims — 34.8% of the state's benzodiazepine prescribing in 2024. Next are Lorazepam (28.4%) and Clonazepam (25.5%).
Source
CMS Medicare Part D Prescribers public use files, data years 2013–2024 (US Government work, public domain). Medicare Part D only — it excludes commercial insurance and cash-pay, skews toward patients 65 and over, and suppresses cells of 10 or fewer claims. Full methodology and limitations are on the national page.